Conexeu Sciences Inc. (NASDAQ:CNXU) Short Interest Update

Conexeu Sciences Inc. (NASDAQ:CNXU) was the recipient of a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 21,639 shares, a growth of ∞ from the May 14th total of 0 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 31,620 shares, the short-interest ratio is presently 0.7 days.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Conexeu Sciences to a “hold” rating in a research report on Saturday, May 30th.

Conexeu Sciences Stock Up 31.1%

Shares of NASDAQ CNXU traded up $3.06 during trading on Tuesday, hitting $12.88. The company had a trading volume of 107,747 shares, compared to its average volume of 94,010. Conexeu Sciences has a 52 week low of $9.60 and a 52 week high of $18.79.

About Conexeu Sciences

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.